Literature DB >> 25141966

Impaired erythrocyte deformability in transgenic HO-1G143H mutant mice.

Gan Chen1, Yujing Yin, Bo Wang, Penglong Li, Qingjun Liu, Guoxing You, Jingxiang Zhao, Sha Xia, Lian Zhao, Hong Zhou.   

Abstract

To investigate the potential effects of variation of HO-1 activity on hemorheology, this study compared the hemorheological properties between transgenic HO-1G143H mutant mice and wild-type (WT) control mice. Fresh blood samples were obtained from mice via the ocular venous sinus. The whole blood viscosity was measured using a cone-plate viscometer. Erythrocyte deformability and aggregation was measured using ektacytometry. The elongation index was significantly reduced in the HO-1G143H mutant mice compared to the WT mice at the shear rates of 600, 800, and 1,000 s(-1). The integrated elongation index was decreased in the HO-1G143H mutant mice compared to the WT mice. There was no statistically significant difference between the HO-1G143H mutant mice and the WT mice in terms of whole blood viscosity, aggregation index, amplitude of aggregation, and aggregation half time. The present study demonstrated that a reduction in HO-1 activity results in an impaired erythrocyte deformability. Although the mechanism underlying this effect remains unclear, our study brings to light the participation of HO-1 in the variations of hemorheology.

Entities:  

Mesh:

Year:  2014        PMID: 25141966     DOI: 10.1007/s11248-014-9829-5

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  33 in total

1.  Capillary recruitment in response to tissue hypoxia and its dependence on red blood cell deformability.

Authors:  K Parthasarathi; H H Lipowsky
Journal:  Am J Physiol       Date:  1999-12

2.  The Laser-assisted Optical Rotational Cell Analyzer (LORCA) as red blood cell aggregometer.

Authors:  M R Hardeman; J G Dobbe; C Ince
Journal:  Clin Hemorheol Microcirc       Date:  2001       Impact factor: 2.375

3.  Impaired red blood cell deformability in patients with coronary artery disease and diabetes mellitus.

Authors:  S Keymel; C Heiss; P Kleinbongard; M Kelm; T Lauer
Journal:  Horm Metab Res       Date:  2011-10-18       Impact factor: 2.936

Review 4.  Structure and function of the spleen.

Authors:  Reina E Mebius; Georg Kraal
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

5.  Blood rheology in diabetes mellitus.

Authors:  S M MacRury; G D Lowe
Journal:  Diabet Med       Date:  1990-05       Impact factor: 4.359

6.  SOD2 deficiency in hematopoietic cells in mice results in reduced red blood cell deformability and increased heme degradation.

Authors:  Joy G Mohanty; Enika Nagababu; Jeffrey S Friedman; Joseph M Rifkind
Journal:  Exp Hematol       Date:  2012-11-06       Impact factor: 3.084

7.  Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension.

Authors:  G Cicco; A Pirrelli
Journal:  Clin Hemorheol Microcirc       Date:  1999       Impact factor: 2.375

8.  The effect of the Gly139His, Gly143His, and Ser142His mouse heme oxygenase-1 mutants on the HO reaction in vivo and in vitro.

Authors:  Lingyun Zhou; Ying Liu; Chaoxia Zou; Ning Ma; Yang Hui; Guixiang Lv; Hongyu Zhang; Hong Zhou; Xu Gao
Journal:  Anat Rec (Hoboken)       Date:  2010-11-16       Impact factor: 2.064

Review 9.  Carbon monoxide: endogenous production, physiological functions, and pharmacological applications.

Authors:  Lingyun Wu; Rui Wang
Journal:  Pharmacol Rev       Date:  2005-12       Impact factor: 25.468

10.  C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients.

Authors:  Thomas Hach; Thomas Forst; Thomas Kunt; Karin Ekberg; Andreas Pfützner; John Wahren
Journal:  Exp Diabetes Res       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.